HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Velasco-Sampayo, A. Articles by Alemany, S. Search for Related Content PubMed PubMed Citation Articles by Velasco-Sampayo, A. Articles by Alemany, S.

p27^kif Protein Levels and E2F Activity Are Targets of Cot Kinase During G₁ Phase Progression in T Cells¹

Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Cientificas, Facultad. Medicina Universidad Autónoma de Madrid, Madrid, Spain

Cot/Tpl-2 kinase, homologous to members of mitogen-activated protein kinase kinase kinase, was initially discovered by its capacity to promote cell transformation. Cot/Tpl-2 mRNA levels are increased during G₀ to G₁ phase progression in T lymphocytes, suggesting a role for this kinase later on in the cell cycle. The IL-2-dependent CTLL-2 cells were used to investigate the role of Cot kinase in G₁ to S phase transition. Transient expression of Cot kinase in CTLL-2 cells increases DNA synthesis triggered by IL-2 and the transient expression of a dominant negative form of Cot kinase in CTLL-2 markedly reduces the DNA synthesis triggered by this cytokine. Cell cycle analysis of synchronized CTLL-2 stabling overexpressing Cot kinase indicates that this kinase contributes to the passage to S and G₂-M phases of the cell cycle. Cot kinase reduces the levels of the cyclin kinase inhibitor p27^kip, whereas bcl-x_L expression is unaffected. Cot kinase also increases E2F transcriptional activity in a phosphatidylinositol 3 kinase-independent way and acts in synergy with this kinase. These data give evidence, for the first time, of the regulation of different G₁ progression events by Cot kinase.

This article has been cited by other articles:

				J. Cho, M. Melnick, G. P. Solidakis, and P. N. Tsichlis Tpl2 (Tumor Progression Locus 2) Phosphorylation at Thr290 Is Induced by Lipopolysaccharide via an I{kappa}-B Kinase-{beta}-dependent Pathway and Is Required for Tpl2 Activation by External Signals J. Biol. Chem., May 27, 2005; 280(21): 20442 - 20448. [Abstract] [Full Text] [PDF]

				J. Cho and P. N. Tsichlis Phosphorylation at Thr-290 regulates Tpl2 binding to NF-{kappa}B1/p105 and Tpl2 activation and degradation by lipopolysaccharide PNAS, February 15, 2005; 102(7): 2350 - 2355. [Abstract] [Full Text] [PDF]

				K. Politi, M. Szabolcs, P. Fisher, A. Kljuic, T. Ludwig, and A. Efstratiadis A Mouse Model of Uterine Leiomyosarcoma Am. J. Pathol., January 1, 2004; 164(1): 325 - 336. [Abstract] [Full Text] [PDF]

				M. Caivano, C. Rodriguez, P. Cohen, and S. Alemany 15-Deoxy-{Delta}12,14-prostaglandin J2 Regulates Endogenous Cot MAPK Kinase Kinase 1 Activity Induced by Lipopolysaccharide J. Biol. Chem., December 26, 2003; 278(52): 52124 - 52130. [Abstract] [Full Text] [PDF]

				M. L. Gandara, P. Lopez, R. Hernando, J. G. Castano, and S. Alemany The COOH-Terminal Domain of Wild-Type Cot Regulates Its Stability and Kinase Specific Activity Mol. Cell. Biol., October 15, 2003; 23(20): 7377 - 7390. [Abstract] [Full Text] [PDF]